• Mylan Launches Wixela Inhub americanpharmaceuticalreview
    March 11, 2020
    Mylan Pharmaceuticals announced the launch of Wixela Inhub (fluticasone propionate and salmeterol inhalation powder, USP), the first available bioequivalent alternative to ADVAIR DISKUS in Canada.
PharmaSources Customer Service